肝素-PEAR1相互作用促进HIT抗体介导的血小板活化
本研究探讨肝素-PEAR1相互作用在肝素诱导的血小板减少症(HIT)血小板活化中的作用。采用洗涤血小板,在肝素存在下以HIT样单克隆抗体5B9和八份HIT血清刺激,评估PEAR1抑制性纳米抗体Nb138的阻断效果。结果显示Nb138可阻断或延迟血小板聚集并降低P-选择素表达,提示肝素-PEAR1轴可能参与HIT病理生理。
要点
- PEAR1阻断可减少HIT样抗体及HIT血清在肝素存在下的血小板活化。
- 肝素-PEAR1轴可能成为HIT血小板活化治疗的潜在靶点。
- 该研究为体外实验,尚需临床验证。
核心结论
- PEAR1阻断可减少或阻断HIT样单克隆抗体及HIT血清在肝素存在下引起的血小板活化,提示肝素-PEAR1轴可能参与HIT的病理生理。
研究设计与样本
- 体外研究,使用多名反应性供者的洗涤血小板,在肝素存在下以HIT样单克隆抗体5B9和八份HIT血清刺激,并设PEAR1抑制性纳米抗体Nb138存在或缺失组。
主要发现
- 肝素(0.5 IU/mL)诱导的聚集和活化可被Nb138(100 nM)阻断。
- 5B9和HIT患者血清在肝素存在下15分钟内诱导完全血小板聚集,Nb138在多数供者中阻断或延迟该聚集。
- 5B9和HIT血清在肝素存在下增加P-选择素表达,Nb138在所有供者中降低该表达。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heparin is a negatively charged, polysaccharide used as an anticoagulant. In 0.5-1% of patients receiving unfractionated heparin, heparin-induced thrombocytopenia (HIT) occurs 5-10 days after exposure. In HIT, heparin binds to platelet factor 4 (PF4), exposing PF4 neoepitopes, allowing binding of heparin-dependent anti-PF4 antibodies, forming immune complexes that activate platelets through FcγRIIA. Recently, we showed that heparin mediates weak/slow aggregation of platelets via platelet endothelial aggregation receptor-1 (PEAR1). OBJECTIVES: To investigate the role of the heparin-PEAR1 interaction in platelet activation in HIT. METHODS: Activation of washed platelets from multiple responsive donors to 5B9 (HIT-like mAb) and eight HIT sera in the presence of heparin, and in the presence or absence of the inhibitory PEAR1 nanobody, Nb138, was assessed. Light transmission aggregometry over 30 minutes was used to measure the kinetics of platelet activation for three sera, whilst flow cytometry for P-selectin expression gave an end read-out after 60 minutes for all eight sera. RESULTS: Aggregation and activation to heparin (0.5 IU/mL) was blocked by Nb138 (100 nM). 5B9 and HIT patient sera in the presence of heparin induced full platelet aggregation within 15 minutes, which was blocked or delayed by Nb138 in most donors. P-selectin expression was increased with 5B9 and HIT sera in the presence of heparin and was reduced by Nb138 in all donors. CONCLUSIONS: Our results demonstrate that PEAR1 blockade reduces/blocks platelet activation to a HIT-like monoclonal antibody and HIT sera in the presence of heparin suggesting the heparin-PEAR1 axis may contribute to the pathophysiology in HIT.
引用
- Buka RJ, Manickam J, Lagonotte H, et al. Heparin-PEAR-1 interaction contributes to platelet activation by HIT antibodies. J Thromb Haemost. 2026. PMID: 42863791. doi:10.1016/j.jtha.2026.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。